| 1 | 
                
                    F2
                
             | 8件:  Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | D06410 
                
                    D06410
                
             | 
                
                    Thrombomodulin Alfa
                
             | 1件:  85 85 | 
| 2 | 
                
                    F2
                
             | 8件:  Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | D07144 
                
                    D07144
                
             | 
                
                    Dabigatran etexilate
                
             | 1件:  51 51 | 
| 3 | 
                
                    F2
                
             | 8件:  Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | D09707 
                
                    D09707
                
             | 
                
                    Dabigatran
                
             | 4件:  51 51, 85, 91, 124 | 
| 4 | 
                
                    F8
                
             | 1件:  Complement and coagulation cascades Complement and coagulation cascades | D00291 
                
                    D00291
                
             | 
                
                    Desmopressin
                
             | 6件:  6 6, 64, 72, 75, 225, 288 | 
| 5 | 
                
                    F8
                
             | 1件:  Complement and coagulation cascades Complement and coagulation cascades | D02235 
                
                    D02235
                
             | 
                
                    Desmopressin
                
             | 6件:  6 6, 64, 72, 75, 225, 288 | 
| 6 | 
                
                    F9
                
             | 1件:  Complement and coagulation cascades Complement and coagulation cascades | D10821 
                
                    D10821
                
             | 
                
                    Emicizumab
                
             | 1件:  288 288 | 
| 7 | 
                
                    F10
                
             | 1件:  Complement and coagulation cascades Complement and coagulation cascades | D03213 
                
                    D03213
                
             | 
                
                    Apixaban
                
             | 3件:  96 96, 97, 222 | 
| 8 | 
                
                    F10
                
             | 1件:  Complement and coagulation cascades Complement and coagulation cascades | D07086 
                
                    D07086
                
             | 
                
                    Rivaroxaban
                
             | 5件:  46 46, 49, 75, 91, 210 | 
| 9 | 
                
                    F10
                
             | 1件:  Complement and coagulation cascades Complement and coagulation cascades | D09710 
                
                    D09710
                
             | 
                
                    Edoxaban
                
             | 2件:  46 46, 88 | 
| 10 | 
                
                    F10
                
             | 1件:  Complement and coagulation cascades Complement and coagulation cascades | D10821 
                
                    D10821
                
             | 
                
                    Emicizumab
                
             | 1件:  288 288 | 
| 11 | 
                
                    FCER1A
                
             | 4件:  Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Fc epsilon RI signaling pathway, Asthma | D05251 
                
                    D05251
                
             | 
                
                    Omalizumab
                
             | 7件:  46 46, 53, 65, 98, 162, 226, 299 | 
| 12 | 
                
                    FCGRT
                
             | - | D11666 
                
                    D11666
                
             | 
                
                    Nipocalimab
                
             | 5件:  11 11, 46, 49, 53, 61 | 
| 13 | 
                
                    FCGRT
                
             | - | D11876 
                
                    D11876
                
             | 
                
                    Efgartigimod alfa
                
             | 4件:  11 11, 14, 35, 63 | 
| 14 | 
                
                    FCGRT
                
             | - | D12144 
                
                    D12144
                
             | 
                
                    Orilanolimab
                
             | 1件:  61 61 | 
| 15 | 
                
                    FCGRT
                
             | - | D12182 
                
                    D12182
                
             | 
                
                    Rozanolixizumab
                
             | 3件:  11 11, 14, 63 | 
| 16 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D00939 
                
                    D00939
                
             | 
                
                    Alendronic acid
                
             | 7件:  19 19, 41, 46, 50, 271, 274, 299 | 
| 17 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D00941 
                
                    D00941
                
             | 
                
                    Pamidronic acid
                
             | 3件:  270 270, 271, 274 | 
| 18 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D00942 
                
                    D00942
                
             | 
                
                    Risedronic acid
                
             | 9件:  46 46, 50, 66, 93, 95, 96, 107, 113, 274 | 
| 19 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D01968 
                
                    D01968
                
             | 
                
                    Zoledronic acid
                
             | 13件:  5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 | 
| 20 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D03234 
                
                    D03234
                
             | 
                
                    Risedronic acid
                
             | 9件:  46 46, 50, 66, 93, 95, 96, 107, 113, 274 | 
| 21 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D06378 
                
                    D06378
                
             | 
                
                    Zoledronic acid
                
             | 13件:  5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 | 
| 22 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D06379 
                
                    D06379
                
             | 
                
                    Zoledronic acid
                
             | 13件:  5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 | 
| 23 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D07119 
                
                    D07119
                
             | 
                
                    Alendronic acid
                
             | 7件:  19 19, 41, 46, 50, 271, 274, 299 | 
| 24 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D07281 
                
                    D07281
                
             | 
                
                    Pamidronic acid
                
             | 3件:  270 270, 271, 274 | 
| 25 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D08056 
                
                    D08056
                
             | 
                
                    Ibandronate
                
             | 3件:  46 46, 49, 274 | 
| 26 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D08484 
                
                    D08484
                
             | 
                
                    Risedronic acid
                
             | 9件:  46 46, 50, 66, 93, 95, 96, 107, 113, 274 | 
| 27 | 
                
                    FDPS
                
             | 4件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | D08689 
                
                    D08689
                
             | 
                
                    Zoledronic acid
                
             | 13件:  5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 | 
| 28 | 
                
                    FGFR1
                
             | 16件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Breast cancer, Central carbon metabolism in cancer | D10481 
                
                    D10481
                
             | 
                
                    Nintedanib
                
             | 5件:  51 51, 85, 89, 227, 228 | 
| 29 | 
                
                    FGFR1
                
             | 16件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Breast cancer, Central carbon metabolism in cancer | D11589 
                
                    D11589
                
             | 
                
                    Infigratinib
                
             | 1件:  276 276 | 
| 30 | 
                
                    FGFR3
                
             | 13件:  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, MicroRNAs in cancer, Bladder cancer, Central carbon metabolism in cancer | D10481 
                
                    D10481
                
             | 
                
                    Nintedanib
                
             | 5件:  51 51, 85, 89, 227, 228 | 
| 31 | 
                
                    FGFR3
                
             | 13件:  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, MicroRNAs in cancer, Bladder cancer, Central carbon metabolism in cancer | D11589 
                
                    D11589
                
             | 
                
                    Infigratinib
                
             | 1件:  276 276 | 
| 32 | 
                
                    FGFR2
                
             | 13件:  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Gastric cancer, Central carbon metabolism in cancer | D05338 
                
                    D05338
                
             | 
                
                    Palifermin
                
             | 5件:  13 13, 36, 38, 39, 65 | 
| 33 | 
                
                    FGFR2
                
             | 13件:  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Gastric cancer, Central carbon metabolism in cancer | D10481 
                
                    D10481
                
             | 
                
                    Nintedanib
                
             | 5件:  51 51, 85, 89, 227, 228 | 
| 34 | 
                
                    FGFR2
                
             | 13件:  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Gastric cancer, Central carbon metabolism in cancer | D11589 
                
                    D11589
                
             | 
                
                    Infigratinib
                
             | 1件:  276 276 | 
| 35 | 
                
                    FLT1
                
             | 9件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | D03218 
                
                    D03218
                
             | 
                
                    Axitinib
                
             | 1件:  34 34 | 
| 36 | 
                
                    FLT1
                
             | 9件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | D06402 
                
                    D06402
                
             | 
                
                    Sunitinib
                
             | 2件:  28 28, 34 | 
| 37 | 
                
                    FLT1
                
             | 9件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | D08552 
                
                    D08552
                
             | 
                
                    Sunitinib
                
             | 2件:  28 28, 34 | 
| 38 | 
                
                    FLT1
                
             | 9件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | D08881 
                
                    D08881
                
             | 
                
                    Cediranib
                
             | 1件:  34 34 | 
| 39 | 
                
                    FLT1
                
             | 9件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | D10481 
                
                    D10481
                
             | 
                
                    Nintedanib
                
             | 5件:  51 51, 85, 89, 227, 228 | 
| 40 | 
                
                    FLT3
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer | D06272 
                
                    D06272
                
             | 
                
                    Sorafenib
                
             | 2件:  34 34, 86 | 
| 41 | 
                
                    FLT3
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer | D06402 
                
                    D06402
                
             | 
                
                    Sunitinib
                
             | 2件:  28 28, 34 | 
| 42 | 
                
                    FLT3
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer | D08524 
                
                    D08524
                
             | 
                
                    Sorafenib
                
             | 2件:  34 34, 86 | 
| 43 | 
                
                    FLT3
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer | D08552 
                
                    D08552
                
             | 
                
                    Sunitinib
                
             | 2件:  28 28, 34 | 
| 44 | 
                
                    FLT3
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer | D11270 
                
                    D11270
                
             | 
                
                    Pexidartinib
                
             | 1件:  34 34 | 
| 45 | 
                
                    FLT4
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D03218 
                
                    D03218
                
             | 
                
                    Axitinib
                
             | 1件:  34 34 | 
| 46 | 
                
                    FLT4
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D06272 
                
                    D06272
                
             | 
                
                    Sorafenib
                
             | 2件:  34 34, 86 | 
| 47 | 
                
                    FLT4
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D06402 
                
                    D06402
                
             | 
                
                    Sunitinib
                
             | 2件:  28 28, 34 | 
| 48 | 
                
                    FLT4
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D08524 
                
                    D08524
                
             | 
                
                    Sorafenib
                
             | 2件:  34 34, 86 | 
| 49 | 
                
                    FLT4
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D08552 
                
                    D08552
                
             | 
                
                    Sunitinib
                
             | 2件:  28 28, 34 | 
| 50 | 
                
                    FLT4
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D08881 
                
                    D08881
                
             | 
                
                    Cediranib
                
             | 1件:  34 34 | 
| 51 | 
                
                    FLT4
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D10481 
                
                    D10481
                
             | 
                
                    Nintedanib
                
             | 5件:  51 51, 85, 89, 227, 228 | 
| 52 | 
                
                    FLT4
                
             | 8件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D11772 
                
                    D11772
                
             | 
                
                    Tesevatinib
                
             | 1件:  67 67 | 
| 53 | 
                
                    FNTA
                
             | 1件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis | D03720 
                
                    D03720
                
             | 
                
                    Tipifarnib
                
             | 1件:  34 34 | 
| 54 | 
                
                    FNTA
                
             | 1件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis | D04768 
                
                    D04768
                
             | 
                
                    Lonafarnib
                
             | 2件:  113 113, 333 | 
| 55 | 
                
                    FNTB
                
             | 1件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis | D03720 
                
                    D03720
                
             | 
                
                    Tipifarnib
                
             | 1件:  34 34 | 
| 56 | 
                
                    FNTB
                
             | 1件:  Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis | D04768 
                
                    D04768
                
             | 
                
                    Lonafarnib
                
             | 2件:  113 113, 333 | 
| 57 | 
                
                    FYN
                
             | 14件:  Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Axon guidance, Osteoclast differentiation, Focal adhesion, Adherens junction, Platelet activation, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Cholinergic synapse, Prion disease, Pathogenic Escherichia coli infection, Viral myocarditis | D03658 
                
                    D03658
                
             | 
                
                    Dasatinib
                
             | 2件:  51 51, 85 | 
| 58 | 
                
                    FYN
                
             | 14件:  Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Axon guidance, Osteoclast differentiation, Focal adhesion, Adherens junction, Platelet activation, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Cholinergic synapse, Prion disease, Pathogenic Escherichia coli infection, Viral myocarditis | D06414 
                
                    D06414
                
             | 
                
                    Dasatinib
                
             | 2件:  51 51, 85 | 
| 59 | 
                
                    FGF23
                
             | 11件:  MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Melanoma, Breast cancer, Gastric cancer | D10913 
                
                    D10913
                
             | 
                
                    Burosumab
                
             | 1件:  238 238 |